Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

71.4%

5 terminated/withdrawn out of 7 trials

Success Rate

28.6%

-57.9% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

200%

4 of 2 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

4(66.7%)

Phase 1

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 2(4)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04401527Phase 2Withdrawn

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

Role: lead

NCT00873015Phase 2Completed

Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

Role: lead

NCT03150420Phase 3Terminated

A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients

Role: lead

NCT03319914Terminated

Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate

Role: lead

NCT00924118Phase 2Completed

Sodium Nitrite in Acute Myocardial Infarction

Role: collaborator

NCT02176837Phase 2Terminated

Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage

Role: lead

NCT01033227Phase 1Terminated

Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease

Role: collaborator

All 7 trials loaded